Possible evidence of systemic lupus erythematosus and periodontal disease association mediated by Toll-like receptors 2 and 4

Clinical and Experimental Immunology

Volumn 183, Issue 2, 2016, Pages 187-192

  Marques, C P C ^a   Maor, Y ^b   de Andrade, M S ^a   Rodrigues, V P ^a   Benatti, B B ^a  

^a FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Connective tissue; Lupus erythematosus; Periodontitis; Toll like receptors

Indexed keywords

TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INCIDENCE; MORBIDITY; MORTALITY; PERIODONTAL DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; GENETICS; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; PATHOPHYSIOLOGY; PERIODONTITIS;

ANIMALS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PERIODONTITIS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84954498898     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12708     Document Type: Review

References (60)

1. Burt B, Greenwell H, Fiorellini J, et al. Position paper: Epidemiology of periodontal diseases. J Periodontol 2005; 76:1406-19.
2. Sanz M, Winkelhoff AJV. Periodontal infections: understanding the complexity - consensus of the Seventh European Workshop on Periodontology. J Clin Periodontol 2011; 38 (Suppl. 11):3-6.
3. Baker PJ, Howe L, Garneau J, Roopenian DC. T cell knockout mice have diminished alveolar bone loss after oral infection with Porphyromonas gingivalis. FEMS Immunol Med Microbiol 2002; 34:45-50.
4. Darveau RP. The oral microbial consortium's interaction with the periodontal innate defense system. DNA Cell Biol 2009; 28:389-95.
5. Berglundh T, Donati M. Aspects of adaptive host response in periodontitis. J Clin Periodontol 2005; 32:87-107.
6. Ali J, Pramond K, Thair MA, Ansari SH. Autoimmune responses in periodontal diseases. Autoimmun Rev 2011; 10:426-31.
7. O'Donnell H, Pham OH, Li LX et al. Toll-like receptor and inflammasome signals converge to amplify the innate bactericidal capacity of T helper 1 cells. Immunity 2014; 40:213-24.
8. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2:675-80.
9. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000; 406:782-7.
10. Mahanonda R, Pichyangkul S. Toll-like receptors and their role in periodontal health and disease. Periodontol 2000 2007; 43:41-55.
11. Ren L, Leung WK, Darveau RP, Jin L. The expression profile of lipopolysaccharide-binding protein, membrane-bound CD14, and Toll-like receptors 2 and 4 in chronic periodontitis. J Periodontol 2005; 76:1950-9.
12. Zarember KA, Godowski PJ. Tissue expression of human Toll-like receptors and differential regulation of toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002; 168:554-61.
13. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11:373-84.
14. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140:805-20.
15. Emingil G, Berdeli A, Baylas H et al. Toll-like receptor 2 and 4 gene polymorphisms in generalized aggressive periodontitis. J Periodontol 2007; 78:1968-77.
16. Lima HR, Gelani V, Fernandes AP et al. The essential role of Toll like receptor-4 in the control of Aggregatibacter actinomycetemcomitans infection in mice. J Clin Periodontol 2010; 37:248-54.]
17. Buduneli N, Özçaka Ö, Nalbantsoy A. Salivary and plasma levels of Toll-like receptor 2 and Toll-like receptor 4 in chronic periodontitis. J Periodontol 2011; 82:878-84.
18. Sales LAR, Falabella MEV, Falabella JM, Teixeira HGC, Figueiredo CMS. Relationship between periodontal disease and systemic lupus erythematosus. Rev Gaucha Odontol 2008; 56:189-93.
19. Pessoa L, Galvão V, Santos-Neto L. Periodontal disease as a risk factor for cardiovascular disease: suggestion of a further link in systemic lupus erythematosus. Med Hyp 2011; 77:286-9.
20. Shao WH, Cohen PL. The role of tyrosine kinases in systemic lupus erythematosus and their potential as therapeutic targets. Exp Rev Clin Immunol 2014; 10:573-82.
21. Su J, Hua X, Concha H, Svenungsson E, Cederholm A, Frostegard J. Natural antibodies against phosphorylcholine as potential protective factors in SLE. Rheumatol 2008; 47:1144-50.
22. Borchers AT, Naguwa SM, Shoenfeld Y, Gershwin ME. The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 2010; 9:A277-87.
23. Katsiari CG, Tsokos GC. Systemic lupus erythematosus: from disease pathogenesis to therapy. Drug Discov Today Dis Mech 2006; 3:185-92.
24. Crispín JC, Liossis SNC, Kis-Toth K et al. Pathogenesis of human systemic lupus erythematosus: recent advances. Trends Mol Med 2010; 16:47-57.
25. Maidhof W, Hilas O. Lupus: an overview of the disease and management options. Pharm Ther 2012; 37:240-9.[Mismatch]
26. Vilar MJP, Sato EI. Estimating the incidence of systemic lupus erythematosus in a tropical region (Natal, Brazil). Lupus 2002; 11:528-32.
27. Lim SS, Bayakly AR, Helmick CG, Gordon C, Easley KA, Drenkard C. The incidence and prevalence of systemic lupus erythematosus, 2002-2004: the Georgia Lupus Registry. Arthritis Rheumatol 2014; 66:357-68.
28. Hopkinson ND, Doherty M, Powell RJ. The prevalence and incidence of systemic lupus erythematosus in Nottingham, UK, 1989-1990. Br J Rheumatol 1993; 32:110-5.
29. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271-7.
30. Chavele K, Ehrenstein MR. Regulatory T-cells in systemic lupus erythematosus and rheumatoid arthritis. FEBS Lett 2011; 585:3603-10.
31. Burch PRJ, Rowell NR. Autoimmunity aetiological aspects of chronic discoid and systemic lupus erythematosus, systemic sclerosis, and Hashimoto's thyroiditis: some immunological implications. Lancet 1963; 282:507-13.
32. Cutolo M, Sulli A, Capellino S et al. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 2004; 13:635-8.
33. Steiner G, Skriner K, Hassfeld W, Smolen JS. Clinical and immunological aspects of autoantibodies to RA33/hnRNP-A/B proteins: a link between RA, SLE and MCTD. Mol Biol Rep 1996; 23:167-71.
34. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005; 17:1-14.
35. Misch EA, Hawn TR. Toll-like receptor polymorphisms and susceptibility to human disease. Clin Sci 2008; 114:347-60.
36. Huang Q, Pope RM. Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis. J Leuk Biol 2010; 88:253-62.
37. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999; 4:1-6.
38. Hwang AM, Stoupel J, Celenti R, Demmer RT, Papapanou PN. Serum antibody responses to periodontal microbiota in chronic and aggressive periodontitis: a postulate revisited. J Periodontol 2014; 85:592-600.
39. Kinane DF, Hart TC. Genes and gene polymorphisms associated with periodontal disease. Crit Rev Oral Biol Med 2003; 14:430-49.
40. Lindhe J, Ranney R, Lamster I, et al. Consensus report: chronic periodontitis. Ann Periodontol 1999; 4:38.
41. Paster BJ, Olsen I, Aas JA, Dewhirst FE. The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontol 2000 2006; 42:80-7.
42. Ozmeric N. Advances in periodontal disease markers. Clin Chim Acta 2004; 343:1-16.
43. Grossi SG, Genco RJ, Machtet EE et al. Assessment of risk for periodontal disease. II. Risk indicators for alveolar bone loss. J Periodontol 1995; 66:23-9.
44. Kim J, Amar S. Periodontal disease and systemic conditions: a bidirectional relationship. Odontology 2006; 94:10-21.
45. Linden GJ, Lyons A, Scannapieco FA. Periodontal systemic associations: review of the evidence. J Clin Periodontol 2013; 40:S8-19.
46. Koutouzis T, Haber D, Shaddox L, Aukil I, Wallet SM. Autoreactivity of serum immunoglobulin to periodontal tissue components: a pilot study. J Periodontol 2009; 80:625-33.
47. Craig RG, Yip JK, So MK, Boylan RJ, Socransky SS, Haffajee AD. Relationship of destructive periodontal disease to the acute-phase response. J Periodontol 2003; 74:1007-16.
48. Hans M, Hans VM. Toll-like receptors and their dual role in periodontitis: a review. J Oral Sci 2011; 53:263-71.
49. Vikerfors A, Johansson AB, Gustafsson JT et al. Clinical manifestations and anti-phospholipid antibodies in 712 patients with systemic lupus erythematosus: evaluation of two diagnostic assays. Rheumatology 2013; 52:501-9.
50. Carneiro-Sampaio M, Liphaus BL, Jesus AA, Silva CA, Oliveira JB, Kiss MH. Understanding systemic lupus erythematosus physiopathology in the light of primary immunodeficiencies. J Clin Immunol 2008; 28:S34-41.
51. Fangtham M, Magder LS, Petri MA. Oral candidiasis in systemic lupus erythematosus. Lupus 2014; 23:684-90.
52. Kobayashi T, Ito S, Yamamoto K et al. Risk of periodontitis in systemic lupus erythematosus is associated with Fc gamma receptor polymorphisms. J Periodontol 2003; 74:378-84.
53. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005; 366:1809-20.
54. Ueki K, Tabeta K, Yoshie H, Yamazaki K . Self-heat shock protein 60 induces tumour necrosis factor-α in monocyte-derived macrophage: possible role in chronic inflammatory periodontal disease. Clin Exp Immunol 2002; 127:72-7.
55. Zügel U, Kaufmann SH . Role of heat shock proteins in protection from and pathogenesis of infectious diseases. Clin Microbiol Rev 1999; 12:19-39.
56. Shoenfeld Y, Sherer Y, Harats D. Artherosclerosis as an infectious, inflammatory and autoimmune disease. Trends Immunol 2001; 22:293-5.
57. Novo E, Garcia-MacGregor E, Viera N, Chaparro N, Crozzoli Y. Periodontitis and anti-neutrophil cytoplasmic antibodies in systemic lupus erythematosus and rheumatoid arthritis: a comparative study. J Periodontol 1999; 70:185-8.
58. Radstake TR, Roelofs MF, Jenniskens YM et al. Expression of Toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-γ. Arthritis Rheum 2004; 50:3856-65.
59. Guggino G, Giardina AR, Ciccia F, Triolo G, Dieli F, Sireci G. Are Toll-like receptors and decoy receptors involved in the immunopathogenesis of systemic lupus erythematosus and lupus-like syndromes? Clin Dev Immunol 2012; 2012:1-5.
60. Fabbri C, Fuller R, Bonfá E, Guedes LK, D'Alleva PSR, Borba EF. Periodontitis treatment improves systemic lupus erythematosus response to immunosuppressive therapy. Clin Rheumatol 2014; 33:505-9.